Acceleron Pharma Inc. (XLRN) Social Stream



Acceleron Pharma Inc. (XLRN): $178.75

-0.93 (-0.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XLRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 474

in industry

Acceleron Pharma Inc (XLRN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Acceleron Pharma Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
13 $155 $100 $131.77 $173.71 -24.14%

The Trend in the Analyst Price Target


Over the past 130 days, XLRN's average price target has gone up $7.6.

XLRN reports an average of 15.56% for its upside potential over the past 165 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-13 13 155 100 131.77 114.03 15.56%
2020-11-06 13 155 100 130.92 NA NA%
2020-10-21 13 155 100 129.85 NA NA%
2020-10-01 13 155 100 129.69 NA NA%
2020-09-19 13 155 89 128.85 NA NA%
2020-08-21 13 155 89 128.85 NA NA%
2020-08-07 12 137 89 126.67 NA NA%
2020-07-17 12 137 88 125.25 NA NA%
2020-07-15 12 137 88 124.00 NA NA%
2020-07-06 12 140 88 124.17 NA NA%
2020-07-01 12 140 88 124.58 NA NA%
2020-06-25 12 140 88 124.58 NA NA%
2020-06-17 12 137 72 117.58 NA NA%
2020-06-01 12 137 72 117.58 NA NA%

XLRN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of XLRN is greater than 2.24% of Pharmaceutical Products stocks.
  • XLRN has a higher average analyst price target than 94.95% of Pharmaceutical Products stocks.
  • Acceleron Pharma Inc's number of analysts covering the stock is higher than 92.01% of Pharmaceutical Products stocks.
  • The variance in analysts' estimates of XLRN is less than 31.9% of all US stocks.

Make investment decisions regarding XLRN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3544 seconds.